ReviewFood science and biotechnology2025
Trends in the recognition system and safety assessments of novel foods in Korea.
Review in Food science and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study examines the recognition systems and safety assessments of novel food ingredients in Korea and other countries, providing insights for developing future safety criteria. It analyzes the recognition status from 2010, when Korea introduced its novel ingredient recognition system, through 2023, reviewing regulations and guidelines from seven major countries, including the Generally Recognized as Safe (GRAS) of the Food and Drug Safety in the USA, the European Food Safety Authority in the European Union, Food Standards Australia New Zealand in the Australia/New Zealand, Health Canada in Canada, Singapore Food Agency in Singapore, and China's National Health Commission in China. The study revealed that most novel food applications in Korea were plant-based, followed by microbial ingredients. By 2023, 72 novel food ingredients had been approved in Korea under the Temporary Standards and Specifications for Foods. This research highlights the growing global interest in novel foods, such as plant-based proteins and microbial fermentation products. It emphasizes the need for Korea to align its safety assessments with internationally coordinated standards. Supplementary Information: The online version contains supplementary material available at 10.1007/s10068-025-01836-9.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.